Iwata, Naomi https://orcid.org/0000-0001-6149-1358
Tomiita, Minako
Kobayashi, Ichiro
Inoue, Yusaburo
Nonaka, Yukiko
Okamoto, Nami
Umebayashi, Hiroaki
Hara, Ryoki
Ito, Yasuhiko
Sato, Yasunori
Mori, Masaaki
Funding for this research was provided by:
Ministry of Health, Labour and Welfare (201510096A)
Article History
Received: 14 February 2020
Accepted: 3 August 2020
First Online: 17 September 2020
Ethics approval and consent to participate
: This manuscript was approved by the ethics committee of Aichi Children’s Health and Medical Center (#2017051), the main study center of the present study. Guardians and patients were provided information by means of an opt-out form.
: Not applicable.
: Tokyo Medical and Dental University (TMDU) received unrestricted research grants for the Department of Lifetime Clinical Immunology from AbbVie GK, Ayumi Pharmaceutical, Chugai Pharmaceutical, CSL Behring, Japan Blood Products Organization, Mitsubishi Tanabe Pharma, Nippon Kayaku, Ono Pharmaceutical, Towa Pharmaceutical, and UCB Japan. TMDU paid the salary of Masaaki Mori.